Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use

    Access Status
    Fulltext not available
    Authors
    Kelty, E.
    Hayes, L.
    O'Neil, G.
    Kyle, S.
    Jeffrey, G.
    O'Neil, G.
    Hendrie, Delia
    Mukhtar, Syed Aqif
    Hulse, G.
    Date
    2014
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Kelty, E. and Hayes, L. and O'Neil, G. and Kyle, S. and Jeffrey, G. and O'Neil, G. and Hendrie, D. et al. 2014. Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use. Journal of Psychopharmacology (Psychopharm). 28 (8): pp. 745-750.
    Source Title
    Journal of Psychopharmacology (Psychopharm)
    DOI
    10.1177/0269881114536791
    ISSN
    1461-7285
    School
    Centre for Population Health Research
    URI
    http://hdl.handle.net/20.500.11937/33057
    Collection
    • Curtin Research Publications
    Abstract

    The harmful use of alcohol places a considerable burden on the community, both socially and financially. The aim of this study was to determine if the use of implant naltrexone is associated with a reduction in health care events and costs in patients treated for problematic alcohol use. Ninety four patients (60.6% male) treated between 2002 and 2007 were matched against state hospital, emergency department (ED), mental health out-patients and mortality data sets for 6 months prior to and 6 months post treatment. The number of patients, events, and costs associated with each health event were compared before and after treatment. Overall health care events and costs were reduced from $509033 prior to treatment to $270001 following treatment. Costs associated with hospital admission showed the most significant reduction, falling from $424605 (82 admissions/36 patients) before treatment to $203462 (43 admission/24 patients) after. While costs associated with ED attendances also fell ($74885 to $54712), costs associated with mental health out-patient attendances increased ($9543 to $11827). The use of implant naltrexone was associated with a reduction health events and costs in patients with problematic alcohol use in the first 6 months following treatment.

    Related items

    Showing items related by title, author, creator and subject.

    • Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone
      Hulse, G.; Morris, N.; Arnold-Reed, D.; Tait, Robert (2009)
      CONTEXT: Oral naltrexone hydrochloride effectively antagonizes heroin, but its utility is limited by patient noncompliance. Sustained-release preparations may overcome this limitation.OBJECTIVE: To compare the safety and ...
    • Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation
      Ngo, H.; Tait, Robert; Hulse, G. (2008)
      Context: Most research on heroin dependence treatments assesses short-term changes in patients' self-reported drug use. To our knowledge, long-term sustainability of changes in patients' drug use and associated hospital ...
    • Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone
      Hulse, G.; Ngo, H.; Tait, Robert (2010)
      Background: Oral naltrexone effectively antagonizes heroin, but patient noncompliance limits its utility; sustained-release preparations may overcome this. Few data are available on optimal blood naltrexone levels for ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.